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1Chapter 1 Introduction
1. INTRODUCTION
1.1 Chemistry of Isatin
Isatin  (1H-indole-  2,  3-dione)  (I)  was  first  discovered  by  Erdmann1 and
Laurent2 in 1841, independently as a product from oxidation of indigo by nitric and
chromic acids. 
(I)                                               (II)
            (Isatin)                                               (Dioxindole)
            It is a unique molecule possessing both amide and keto carbonyl groups.  A
part from this, it has an active hydrogen atom attached to nitrogen (or oxygen) and
an  aromatic  ring  which  was  substituted  at  5-  and  7-positions.   It  exists  in  a
tautomeric form (II) and these functional characteristics play an important role in
governing the various reactions of the molecule. 
The C-3 carbonyl group of isatin is strongly electrophilic.  As a result, isatins
are  readily involved  in  condensation  and  addition  reactions  with  carbanion  type
nucleophiles into 3-substituted oxindoles3.  In general, there are three possibilities
during condensation reactions. 
i. Both the , α-carbonyl groups, having varying in reactivity are involved, 
ii. Ring cleavage takes place and 
iii. Ring expansion occurs
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A general observation reveals that the nature of final product always depends
on the experimental conditions and substituent on nitrogen atom which may affect
the electron density at β and α carbonyl carbon atoms respectively4.
The Sandmeyer methodology
This method is  applied mostly well  to anilines with electron-withdrawing
Substituents, such as 2-fluoroaniline5 (1).
(Substituted aniline)                (Isonitrosoacetanilide)      (Substituted isatin)
                                                               (1)
                                                          Scheme-1
In addition to the use of H2SO4 for the cyclization step, isonitrosoacetanilide
is heated in BF3.Et2O at 90oC.  After cooling the reaction mixture, addition of water
allows isolation of the respective isatins.  This methodology has been proved to be
particularly effective for the preparation of benzo-oxygenated isatin derivatives6, 7.
The Stolle procedure
The most important alternative to Sandmeyer’s procedure is the method of
Stolle.  In this method anilines react with oxalyl chloride to form an intermediate
chloro-oxalylanilide which can be cyclized in the presence of a Lewis acid, usually
aluminium chloride  or  BF3.Et2O, although TiCl4 has  also  been  used  to  give  the
corresponding isatin.  This method has been used for the synthesis of 1-aryl8 and
polycyclic isatins derived from phenoxazine, phenothiazine and dibenzoazepine9 as
well  as  indoline10.   In  the case of  dimethoxyanilines,  spontaneous cyclization to
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yield  dimethoxyisatins  in  the  absence  of  a  Lewis  acid  has  been  observed,  as
exemplified in the synthesis of melosatin A (2), albeit in very low yield (Scheme-2). 
(2, 3-Dimethoxy (5-methyl benzyl) aniline)
(2)
Scheme-2
The Martinet Isatin synthesis
The Martinet procedure for the synthesis of indole-2,3-diones involves the
reaction of  an amino aromatic  compound and either  an oxomalonate ester  or  its
hydrate in the presence of  an acid to yield a 3-(3-hydroxy-2-oxindole)carboxylic
acid derivative which after oxidative decarboxylation yields the respective isatin (3).
This  method was applied successfully for  the synthesis  of 5,  6-dimethoxy isatin
from  4-aminoveratrole  whereas  the  use  of  2,  4-dimethoxyaniline  was  less
successful11.
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                                         (5, 6-Dimethoxy isatin)
(3)
Scheme-3
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The Martinet procedure is readily applied to naphthylamines, thus yielding 
benzoisatin derivatives12. 
The Gassman procedure
A fundamentally different and general procedure developed by Gassman is
another  option  for  the  synthesis  of  isatins13.   This  methodology  consists  in  the
formation and subsequent oxidation of an intermediate 3-methylthio-2-oxindole to
give the corresponding substituted isatins (4) in 40-81% yield. 
            Two complementary methods for the synthesis of the 3-methylthio-2-
oxindoles were developed, and the methodology of choice is dependent upon the
electronic  effect  of  substituents  bonded  to  the  aromatic  ring.   When  electron-
withdrawing groups are present, the oxindole derivative can be synthesized via  N-
chloroaniline intermediate, which further reacts with a methyl thioacetate ester to
furnish an azasulfonium salt (Method 1, Scheme 4).  In the case of electron-donating
groups that destabilize the N-chloro intermediate, and thus give diminished yields of
the azasulfonium salt, a second method of generation of this salt, by reaction of the
chlorosulfonium salt with appropriate aniline, gives better yield of the 3-methylthio-
2-oxindoles. 
                                       (4)     (Substituted isatin)
Scheme-4
Dept. of Pharmaceutical Chemistry           J.K.K. Nattraja College of Pharmacy
6Chapter 1 Introduction
Metalation of anilide derivatives
A more recent method for the synthesis of isatins is based upon the directed
ortho-metalation  (DoM)  of  N-pivaloyl-  and  N-(t-butoxycarbonyl)-anilines.   The
corresponding dianions are treated with diethyl oxalate and the isatins are obtained
after deprotection and cyclisation of the intermediate β-ketoesters.  This method has
the advantage of being regioselective for the synthesis of 4-substituted isatins  (5)
from meta-substituted anilines where the substituent is a metalation directing group
(e.g., OMe) 14(Scheme-5). 
(5)
(N-(t-butoxycarbonyl)-aniline)                                                (4-Substituted isatin)
Scheme-5
The  synthesis  of  5-azaisatin  was  realized  by  ortho-lithiation  of  the  4-
aminopyridine  t-butylcarbamate  followed  by  reaction  with  an  excess  of  diethyl
oxalate.  Heating the glyoxylic ester under vacuum gave 5-azaisatin15 (6) (Scheme
6).
(4-Aminopyridine t-butylcarbamate)                                        (5-Azaisatin)
Scheme-6
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               Recently,  a metal-halogen exchange method was described for the
synthesis  of  isatins  by  lithiation  of  ortho-bromophenylureas,  carbonization  and
subsequent intermolecular cyclisation to give the desired products  (7) in 71-79%
yield16 (Scheme-7).
(O-Bromo phenylurea)                                                             (Substituted isatin)
                                                           Scheme-7                                       (7)
Other methods
A)  Ring contraction method17
A number  of  2,  4-dihydroxy  quinolones,  after  the  introduction  of  a  3-
hydroxyimino, 3-nitroso, 3-hydroxy-3-amino or 3, 3-dihalo groups gives isatins (8)
with sulphuric acid or sodium hydroxide (Scheme-8).
(2, 4-Dihydroxy quinolone)  (3, 3-Dichloro (2, 4-dihydroxy) quinolone)   (8)  
Scheme-8
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B)  From indole derivatives18
A number of oxindoles have been treated with nitrous acid to give isatin-3-
oximes.  Reduction of the oximes to 3-amino oxindoles followed by ferric chloride
oxidation gives Isatins (Scheme-9). 
Scheme-9
C)  Heller’s method19
In this method isatin is obtained by heating o-hydroxyl amino mandelic acid 
with hydrochloric acid (Scheme-10). 
Scheme-10
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D)  Reissert’s method 20
A synthesis developed by Reissert depends on heating thio-oxanilide with
conc. sulphuric acid (Scheme-11). 
(N-Hexyl thio-oxanilide)                  (Isatin)
 Scheme-11
E)  Claisen-Shadwell synthesis21
O-Nitro benzoyl  cyanide  prepared  from  o-nitro  benzoyl  chloride  and
potassium cyanide can be hydrolyzed and then reduced to the salt of o-amino phenyl
glycoxylic acid with ferrous hydroxide.  Acidification of the solution of glyoxylate
affords Isatin (8) (Scheme-12). 
(O-nitro benzoyl chloride)                 (O-amino phenyl glyoxalicacid)     (Isatin)   
Scheme-12
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1.2 Reactions of Isatin
The reactive carbonyl group at position-3 undergoes typical reactions with
the  ketonic  reagents  such  as  hydroxylamine22,  phenyl  hydrazine23 and
semicarbazide24.  The carbonyl group at position-2 is less active and has less ketonic
character compared with carbonyl group at C3 (Scheme-13).
Scheme-13
Schiff bases
Isatin reacts with a variety of aromatic amines25 in the presence of glacial
acetic acid to yield Schiff bases (9) (Scheme-14).
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Scheme-14
Mannich reaction26 
Isatin  reacts  with  formaldehyde  and  a  variety  of  amines  in  the  Mannich
reaction to give their respective Mannich bases, in the absence of an amine, isatin
and substituted isatin with formaldehyde give hydroxymethyl isatins (Scheme-15). 
            (Hydroxy methyl isatin)                           
                                                                 Scheme-15
Aliphatic primary amines
Primary aliphatic amines27 are also reported to give imines with isatin.  Isatin
and N-methyl isatin can be reacted with ammonia to give imines’ (10) (Scheme-16). 
         (N-Substituted isatin)                                       (N-Substituted imine)
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Scheme-16
N-Substituted Isatins 
Acylation and Alkylation 
Isatin  sodium or  potassium or  silver  salts  react  with  dimethyl  or  diethyl
sulfate, a variety of alkyl halides, and anhydride28 to give N-alkyl and N-acyl isatins.
Isatin and triethylamine with phenyl and methyl isocyanate has reported to
give 1-carboxamidoisatin29  (11).  In alkali, however isatin and phenyl isocyanate or
phenyl isothiocyanate to give the quinazolines30
 
(12). 
                       (1-Carboxamidoisatin)                 (Substituted quinazoline)
Other reactions of Isatins
a) Electrophilic substitution and related reactions 
Reagents  such  as  N-bromosuccinimide,  N-chlorosuccinimide,  N-bromo
caprolactam, sulfuryl chloride, bromine, t-butyl hypochlorite and I or Cl have been
used to prepare 5-haloisatins.  Chlorination (halogenations) of 6 and 4-chloroisatin,,
alkylation  leads  to  halogenation  at  5  position,31-34.   If  the  5-position  is  occupied
halogenation takes place in the 7-position. 
                                            Nitration of isatin, 7-methyl isatin, 4,7-dimethyl isatin and 1-ethyl
isatin leads to the introduction of the nitro group into the 5-position.  Nitration of 5-
methyl isatin gives 5-methyl-7-nitro isatin. 
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b)  Oxidation
Oxidation reaction of isatin yields anthranilic acid with alkaline hydrogen
peroxide.  The oxidation has been applied to alkyl, halo, alkoxy, trifluro methyl and
nitro  isatins.  Oxidation  with  chromium  trioxide  in  acetic  acid,  chromium
trioxide in acetic anhydride – acetic acid35, 3-chloro per benzoic acid (13) in
methylene chloride36 or benzene give rise to isatoic anhydride (14). 
           (3-Substituted perbenzoic acid)                          (Isatoic anhydride)
c) Reduction
Isatin derivatives when reduced with sodium hydro sulfite, zinc-copper leads
to the corresponding oxindole (15). 
(Substituted oxindole)
(15)
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Lithium Aluminium hydride reduction of isatin gives mixture of 3- hydroxy
indole,  indole,  indigo  and  indirubin.   However,  lialh4 is  used  to  convert,  4,5,6-
trimethoxy isatin, 5-bromo isatin, 4,6-dimethoxy isatin, 1-ethyl and 1-methyl isatin
to the corresponding indoles.   Catalytic  hydrogenation  of  isatin  gives  oxindoles,
whereas electrolytic reduction using a lead electrode gives dihydroxy indole37. 
d) Condensation involving carbon at C-3
Isatin on condensation with a wide variety of ketones yields 3-hydroxy-3-
substituted oxindoles38 (16, 17). 
(16) (17)
Isatin  and  its  derivatives  have  reacted  with  both aryl  and  alkyl  Grignard
reagents to give 3-alkyl (or aryl) dioxindoles. 
e)  Reaction of N-substituents 
Reaction of N-hydroxy isatin with acetic anhydride gives compound39 (18)
whereas methyl isocyanate in phenyl diazo methane gives compound40 (19).  Isatin
Mannich reaction products have been reacted with active hydrogen compounds to
yield their respective Mannich bases41 (20).   
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(N-Acetyl isatin)        (N-(N-Methyl amido) isatin)   (N-(N-Substituted
methyl) isatin)                 
                     (18)                                         (19)                                                 (20)
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2. REVIEW OF LITERATURE
Isatin and several of their derivatives have been generally associated with
various biological and pharmacological properties.  The synthesis of a large number
of isatin derivatives have been described to obtain biologically potent compounds.
Many such compounds have been found to be promising.  A few even have clinical
application also. 
This prominence aroused interest to several chemists and medicinal chemists
to prepare day to day newer and newer potential  isatin derivatives by molecular
conjunction approach and evaluating them for possible pharmacological actions. 
Since there have been numerous reports, it is highly impossible to cover all
such  reports  in  a  single  review.  Hence,  it  is  chosen  to  present  some interesting
reports of the recent two decades on the topic, mainly to indicate the recent trends in
the progress of research on isatin derivatives.  It is needless to quote that it is not at
all an easy task to cover even these two decades, meticulously.  However, efforts
have been made to cover very broadly but briefly. 
The present  survey aims  to  synthesize  of  some new isatin  derivatives  of
specific biological and pharmacological activity and looking for such activity (or)
activities by their evaluation experimentally. 
Since there have been numerous reports, some of the interesting reports are
presented here according to their biological / pharmacological activity for orderly
presentation.
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ISATINS AS ANTIMICROBIAL AGENTS
Isatin  itself  is  inhibitory  to  the  growth  of  Tubercle  bacillus.  Isatin-β-
thiosemicarbazone  was  described  as  antibacterial  by  various  workers.  This
compound was found to be effective against tubercle bacillus to some extent.
M. Carcelli et al., 42 reported the properties of organotin (IV) complexes with
isatin  and  N-alkalization  bisthiocarbohydrazones  (21) against  antimicrobial  and
mutagenic property.
     
          Padhy et al., 43 reported the synthesis of 1-acetyl-3-(2-acetoxy-3-substituted
propyloximine)  indol-2-(3H)-ones  (22)  and  evaluated  for  antimicrobial  activity
against  B. subtilis, E. coli and  C. albicans.  Among them, the compound with 2-
acetoxy-3-substituted  propyloximino  chain  at  3-position  of  indole-2,  3-dione
exhibited high activity with MIC of 0.35 g/ml to 12.5 µg/ml against B. subtilis, 0.16
– 3.12 µg/ml against E. coli and 6.2 – 100 µg/ml against C. albicans.
R  –  Piperidino;  pyrrolidino;  dicyclohexylamino;  diphenylamino;
methylphenylamino   
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Ravi raj  A. Kusanur  et  al., 44 reported the synthesis of 4'-(coumarin-3-yl)
spiro [3H-indol-3,2'-1,5-benzodiazepine]-2(1H)-one  (23) and evaluated for  in vitro
antibacterial activity. 
Among all  the compounds, compound with R = 8-OCH3,  R1 = R2 = CH3
showed 88.83% of inhibition against B. subtilis and 77.77% of inhibition against E.
coli as compared to the standard and other compounds were moderately active. 
Gupta  et al., 45 reported the synthesis of 1,3-dihydro-5-substituted-3-[[4-[1-
(p-sulphamylphenylimino)ethyl)phenyl]imino]-2H-indol-2-ones  (24) and  screened
them for in vitro antibacterial activity.  Compounds with X = H, R = diazino; X = Cl,
R = H; X = Cl, R = -C (=NH) NH2; X = Cl, R = diazino and X = Cl, R = dimidino
showed highest activity against B. subtilis and S. aureus. 
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 Ajitha  et  al., 46 reported  the  synthesis  of  new  2-substituted-[1,  3,  4]-
oxadiazino-[6,  5-b]-indoles  (25).   The  compounds  were  evaluated  for  in  vitro
antimicrobial activity.  Compounds (R = Cl, R1 = H, R2 = benzimidazolyl), (R = Br,
R1 =  H,  R2 =  benzimidazolyl)  showed  highest  antimicrobial  activity  which  was
comparable with that of Ampicillin. 
Varma and Vinita Bajpai 47prepared a new series of 1-heteryl aminomethyl-3-
(4'-acetylamino-3'-chlorobenzoylhydrazono)-2-indolinones  (26) as  potential
antimycotics.   Amongst  the  compounds  tested,  the  compounds  in  which  (Z  =
morpholino,  piperidino,  R  =  H,  Br)  respectively  displayed  significant  activity
against T. Mentha grophytes (MIC – 50 µg/ml)
Havaldar and Mishra  48prepared 1-(substituted amino methyl)-3-(3'-bromo-
4'-methoxybenzoylhydrazone)  indolin-2-ones  (27) and  screened  for  in  vitro
antibacterial and antifungal activities.  Compound with X = morpholino, piperidino
showed highest activity against S. aureus and C. albicans. . 
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Pardasani  et al., 49prepared some fused and Spiro imidazolidine derivatives
(28, 29) and subjected for antimicrobial activity.  The compounds showed significant
inhibitory activity against two bacteria.
Mogilaiah et al.,  50 reported the synthesis and antibacterial activity of some
new [1,  3,  4]  oxadiazino [6,  5-b]indoles  (30),  Compounds with R = 6-Cl &  p-
chlorophenyl showed significant inhibitory activity against E. Coli and B. Subtilis.
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Anees A. Siddiqui  et al., 51 reported the synthesis of 2', 3’ [b]-indolyl-1, 4-
quinoxaline  derivatives  (31) and  evaluated  them  for  antibacterial  activity.   The
compounds exhibited very mild antibacterial activity. 
Alagarsamy et al., 52 prepared 3-(pyridyl-4-carbonylamino) Spiro (3H-indol-
3,  2-thiazolidine)-2,  4’-(1H)  Dione  (32) and  evaluated for  antimicrobial  activity.
The compound showed equipotent activity with that of standard drug employed. 
Pandeya  et al., 53 prepared N-Mannich bases of 3-(4-sulphadiazinyl)-isatins
(33) and screened them for in vitro antimicrobial activity. 
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ISATIN AS ANTIVIRAL AGENTS
Debra  C.Quenelle  et  al., 54  reported  the  synthesis  of  isatin  β-
thiosemicarbazone and N-methyl-isatin-β-thiosemicarbazone (34) for in vitro and in
vivo evaluation against Cowpox virus infections.
Selvam et al., 55 reported 4-[(1, 2-dihydro-2-oxo-3H-indol-3-ylidene) amino]-
N-(4,  6-dimethyl-2-pyrimidinyl)-benzene sulphonamide and its  derivatives.   They
were synthesized by the reaction of isatin and its derivatives with sulphadimidine.
The anti-HIV activity of  the compounds was tested against  replication of  HIV-1
(IIIB) and HIV-2 (ROD) strains in acutely infected MT-4 cells and the activity was
compared with the standard Azidothymidine.
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Among the  compounds  tested,  4-[(1,  2-dihydro-2-oxo-3H-indol-3-ylidene)
amino]-N-(4,  6-dimethyl-2-pyrimidinyl)-benzene  sulphonamide  (35)  and  its  N-
acetyl derivatives were the most active compounds.
Shin-Hun Juang  et al., 56 were synthesized N-substituted isatin derivatives
(36)  from the reaction of isatin and various bromides via two steps.  Bioactivity
assay results (in vitro test) demonstrated that some of these compounds are potent
and selective inhibitors against SARS corona virus 3CL protease with IC50 values
ranging from 0.95 to 17.50 µM 
Luhua  Lai  and  Lu  Zhou  57, reported,  a  series  of  N-substituted  isatin
derivatives (37) were synthesized and tested against SARS CoV 3C-like protease
using a colorimetric assay and confirmed by HPLC.  The compounds were shown to
be  noncovalent  reversible  inhibitors  of  SARS  CoV  3C-like  protease.  The  C-5
position was found to favour a carboxamide group and N-1 position to favour large
hydrophoretic substituents. 
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The lowest IC50 value (0.37 µM) was observed with compound if and it was
selective for SARS CoV 3C-like protease over other protease.
Dharmarajan Sriram et al., 58 reported a series of isatin β-thiosemicarbazone
derivatives (38) was synthesized and evaluated for their anti-HIV activity in HTLV-
IIIB strain in CEM cell line.
              
ISATINS AS ANTICANCER AGENTS
Kara L-vine  et al.,  59 reported the  in vitro cytotoxicity evaluation of some
substituted isatin derivatives (39, 40).
Twenty three compounds were synthesized and tested four were selected for
further screening against a panel of five human cancer cell lines.  These compounds,
in general,  showed greater selectivity reward leukemia and lymphoma cells  over
breast, prostate and colorectal carcinoma cells.
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Klaus  Kopka  et  al.,  60  reported  5-pyrrolidinyl  sulfonyl  (41) isatins  as  a
potential tool for the molecular imaging of carpases in apoptosis.
Ashraf H. Abadi et al., 61 reported synthesis of 3-substituted-2-oxoindole (42)
analogues evaluated anti cancer activity.
Upal Kanti Mazumder et al., 62 reported the synthesis, anticancer and 
antibacterial activities of some novel mononuclear Ru (II) complexes (43).
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All  the  complexes  were  tested  for  their  anticancer  activity  against  EAC
bearing mice.  RU1-RU4 was found to increase the life span of the tumor hosts by
66-43% and was the most active in the series of synthesized complexes.  RU1-RU4
was  also  found  to  bring  the  altered  haemoglobin  and  RBC values  of  the  EAC
bearing mice to near normal values.   
Rafiqul Islam et al.,  63 reported the synthesis of 5-spiro (5'-methylisatin)-4-
acetyl-2-(acetyl  amino)-µ2-1,3,4-thiadiazoline  and  5-spiro  (5'-methylisatin-3'-
hydrazino)-∆2-1, 3, 4-thiadiazoline (44-47).
The anticancer  activity of  the  synthesized compounds  was  carried  out  by Brine
Shrimp Lethality test and in vitro anticancer cell lines assay against various cancer
cells.  
ISATINS AS ANALGESICS, ANTIPYRETICS AND ANTI-INFLAMMATORY
AGENTS
Patricia Dias et al., 64 designed to investigate the inhibitory effect of isatin
on  lipopolysaccharide/interferon-γ  induced  expression  of  inducible  nitric  oxide
synthase (iNOS) and COX-2 (48).
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Sridhar and Ramesh 65 reported the synthesis of Schiff bases and hydrazones
of isatins (49). They were evaluated for analgesic, anti-inflammatory and antipyretic
activities.     
The compounds with 5-chloro group exhibited significant antipyretic activity
whereas 5-methyl group exhibited moderate anti-inflammatory activity respectively.
Suroor A. Khan et al., 66 reported the synthesis of Schiff bases of isatin (50) 
and they were evaluated for analgesic activity.  These compounds were found to be 
less activity than Aspirin. 
S.N.  Pandeya  et  al.,  67reported the synthesis and antimicrobial  activity of
some Schiff and mannich bases of isatin and its derivatives with pyrimidine. All the
tested compounds were showed mild to moderate activity against bacteria.
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ISATIN AS CNS AGENT
Anticonvulsant activity
Olesen and Kanstrup68 prepared pyrido [2, 3-b] indoles to treat a disease in
the CNS via the metabotrophic glutamate receptor system. The title compounds are
useful  for  treating  diseases  in  the  CNS  such  as  epilepsy,  senile  dementia  and
Parkinsonism (52).
Evanno  et  al., 69 synthesized  1H-pyrido  [3,  4-b]  indole-4-carboxamide
derivatives (53).  
The different  substituted compounds (53)  were tested for  their anxiolytic,
hypnotic and anticonvulsant activities.
Evanno  et  al., 70 synthesized  4-oxo-3,5–dihydro-4-H-pyridazano-4,5-b-
indole-1-acetamide  derivatives  that  can  be  used  for  treating  diseases  related  to
GABA aminergic transmission disorders. The compounds also shows hypnotic and
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anticonvulsant activities in rats and mice. The structures of the compounds are given
in (54).
      
David  et  al., 71 have shown that  2-aminonapthyridine is  prepared by ring
cleavage of 2-isoindolinyl napthyridine (55).
These  compounds  have  exhibited  remarkable  anxiolytic,  hypnotic,  and
anticonvulsant and muscle relaxant properties.
Srivastava et al., 72 synthesized a series of compounds from carbazole, which
on condensation with chloroacetyl chloride in the presence of triethylamine afforded
azetidinones. Some of the compounds exhibited promising antibacterial, antifungal,
anti-inflammatory and anticonvulsant activities (56).
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Singh  et  al., 73 synthesized  a  series  of  isatin-based  spiroazetidinones  and
screened them for their anticonvulsant activity (57).
Pandeya  et  al.,74 synthesized  a  series  of  p-nitro  phenyl  substituted
semicarbazones  and  their  anticonvulsant  activity  was  screened  against  maximal
electroshock  (MES),  subcutaneous  pentylenetetrazole  (ScPTZ)  and  subcutaneous
strychnine  (ScSTY)  tests  (58).  All  the  compounds  were  active  in  subcutaneous
pentylenetetrazole and MES tests. Two compounds were active in the MES test at
100 mg kg–1. 
Pandeya  et  al., 75 synthesized  a series  of  N-methyl/acetyl-5-unsubstituted-
isatin-3-semicarbazones (58).
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In this series, compounds with 4-bromo and 2-chloro substitution (R = 4-Br
and 2-Cl) showed promising activity and were also active in MES, subcutaneous
pentylenetetrazole and subcutaneous strychnine induced tests.
Further, Pandeya et al., 76 synthesized halo substituted isatin semicarbazones
to study the role of hydrogen bonding for anticonvulsant activity (59). 
Pandeya  et  al.,77 had  synthesized  Schiff  bases  of  N-methyl  and  N-acetyl
isatin derivatives with different aryl amines and screened them for anticonvulsant
activity against MES and scMet. N-methyl-5-bromo-3-(p-chlorophenylimino) isatin
exhibited anticonvulsant activity in MES and scMet with  LD50 > 600 mg kg–1,
showing better activity than the standard drugs such as phenytoin, carbamazepine
and valproic acid (60).
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Anxiogenic and other CNS activities 
Palit  et al., 78 studied the behavioral effects of isatin, a putative biological
factor in rhesus monkeys.  Isatin,  one of the constituents of tribulin,  a postulated
endocoid marker of stress and anxiety, has been shown to induce anxiety in rodents.
Medvedev et al., 79 studied a range of isatin analogues for their in vitro inhibition of
human MAO A and B. Most analogues were less potent than isatin.  Hydroxylation
of the aromatic ring in isatin changed the inhibitory potency in favour of MAO A,
with 5-hydroxy isatin being a potent and selective MAO A inhibitor (IC50 8 ∆g mL–
1). Isatinic acid, which is formed reversibly from isatin in alkaline medium, showed
no inhibition (61).
  
Kennis et al., 80 synthesized hexahydropyrido (4, 3-b) indole derivatives.
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The compound displayed in  (62) was found to have central dopamine and
serotonin antagonistic activity in the combined apomorphine, tryptamine and nor-
epinephrine test in rats.
Sarangapani  et  al., 81 reported  the  synthesis  of  3-methyl-4-(oxindol-3-
ylidenyl)-5-pyrazolones  (63).  All compounds screened for gross behavior studies
they exhibited CNS depression, reduced loco motor activity.  Compounds with 5-
CH3 group  on  indolinone  and  3-methyl  group  on  pyrazole  showed  antibacterial
activity.
Maria Eline Mathew82 has  designed to  investigate the inhibitory effect  of
isatin  derivatives  on  lipo  polysaccharide  /  interferon-µ-induced  expression  of
inducible  nitric  oxide  synthase  (iNOS)  and  cyclooxygenase-2-  (Cox-2)  proteins,
production of  prostaglandin  E2 (PGE2),  nitric  oxide  (NO),  tumor  necrosis  factor
(TNF-γ) and their capacity to scavenge NO.  Isatins (64) inhibit TNF-α production
and iNOS and COX-2 protein expression resulting on reduced levels of NO & PGE2.
Giscle  Zapata  et  al., 83 reported the  synthesis  of  novel  isatin  ketals  (nine
dioxolane  ketals  and  nine  dioxane  ketals)  (65) and  studied  for  their  sedative,
hypnotic  and  anesthetic  effects  using  pentobarbital  induced  sleeping  time,  loco
motor activity
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They observed dioxolane ketals were more potent than dioxane ketals for
inducing  sedative-hypnotic  states,  causing  up  to  a  three-fold  increase  in
pentobarbital hyperosis.
Sasmal  et al., 84 reported synthesis and evaluation of CNS activity of some
Spiro  isationoid  compounds (66).   All  compounds  exhibited  CNS depression  in
mice. 
 
Isatins as psychotropic agents
Varma et al., 85 reported the synthesis of alkyl-4-[4'-(1,2-dihydro-5-chloro-2-
oxo-3H-indol-3-ylidene amino)benzoyl]aminobenzoate (67) and the Mannich bases
of  these  compounds  (68) with  morpholine  were  found  to  be  non-toxic  and
psychotropic.  Some of these compounds were also active against mycobacterium
tuberculosis. 
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Effect of indoles on pentobarbitone induced sleeping time:
Sarangapani et al., 86   reported eight new 2-substituted-[1, 3, 4] oxadiazino-
[6, 5-b] indoles (69).  All the compounds exhibited reduction in loco motor activity
and potentiating of pentobarbitone sodium induced sleeping time in experimental
animals. 
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3. AIM AND PLAN OF WORK 
           It is evident from literature that the presence of the indole nucleus found to
have various pharmacological  activities like antimicrobial,  anti-convulsant,  MAO
inhibitory, anticancer and psychotropic activities. The very fact that one of indole
derivatives  (Isatins)  is  potential  synthons,  for  building  synthetically a  variety  of
chemical  systems  known  for  their  broader  biological  and  pharmacological
applications.  
Field of chemistry of isatin remains always a fresh and even challenging for
their further explorations and exploitation. It is interesting to note from the literature
that  the  important  isatin  moiety  is  yet  to  be  explored  both  synthetically  and
biologically in spite of the extensive work reported so far on isatins. 
Therefore, keeping this in view as the main objective, the present project has
been aimed at achieving the following:
 To synthesize the Isatin derivatives as depicted in Scheme-17.
 To purify the new isatin derivatives by crystallization and chromatographic 
techniques.
 To characterize the new compounds by physical and spectral data (IR, 1H 
NMR and Mass)
 To screen the compounds for their biological activity by standard protocols 
available in literature.
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Table 1: Structures of aromatic aldehydes used 
Compounds Structures Compounds Structures
      Va
CHO
benzaldehyde
     Vf
FOHC
4-fluorobenzaldehyde
     Vb
OCH3OHC
4-methoxybenzaldehyde
     Vg
OCH3OHC
OCH3
3,4-dimethoxybenzaldehyde
     Vc
OHOHC
OCH3
4-hydroxy-3-methoxybenzaldehyd
     Vh  OHC
OH
2-hydroxybenzaldehyde
     Vd
ClOHC
4-chlorobenzaldehyde
     Vi
OHC N
CH3
CH3
4-(dimethylamino)benzaldehyde
     Ve
NOOHC
4-nitrobenzaldehyde
     Vj
HCHCOHC
cinnamaldehyde
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Table 2:  List of compounds to be synthesized  
Compounds Structure & IUPAC names
Va
HN
O
N N CH
3-[(2-phenyl methylidene) hydrazono]-1, 3-dihydro-2H-benzo 
[g]indol-2-one.
Vb
HN
O
N N CH O
3-[(2)-(4-methoxy phenyl methylidene) hydrazono]-1, 3-
dihydro-2H-benzo[g]indol-2-one.
Vc
HN
O
N N CH
OC
3-[(2)-(4-hydroxy-3-methoxy phenyl methylidene) hydrazono]-
1, 3-dihydro-2H-benzo[g]indol-2-one.
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Compounds Structure & IUPAC names
Vd
HN
O
N N CH
3-[(2)-(4-chloro phenyl methylidene) hydrazono]-1, 3-dihydro-
2H-benzo[g]indol-2-one 
Ve
HN
O
N N CH
3-[(2)-(4-nitro phenyl methylidene) hydrazono]-1, 3-dihydro-2H-
benzo[g]indol-2-one. 
Vf
HN
O
N N CH
3-[(2)-(4-floro phenyl methylidene) hydrazono]-1, 3-dihydro-2H-
benzo[g]indol-2-one.
Vg
HN
O
N N CH OC
OCH3
3-[(2)-(3, 4-dimethoxy phenyl methylidene) hydrazono]-1, 3-
dihydro-2H-benzo[g]indol-2-one.
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Compounds Structure & IUPAC names
Vh
HN
O
N N CH
OH
 3-[(2)-(2-hydroxy phenyl methylidene) hydrazono]-1, 3-
dihydro-2H-benzo[g]indol-2-one.
Vi
HN
O
N N CH N
CH
CH
3-[(2)-(4-(N, N dimethyl) amino phenyl methylidene) 
hydrazono]-1, 3-dihydro-2H-benzo[g]indol-2-one.
Vj
HN
O
N N C
H
C
H
C
H
3-[(2)-(3-phenyl allylidene) hydrazono]-1, 3-dihydro-2H-
benzo[g] indol-2-one.
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4. EXPERIMENTAL WORK
4.1 Materials and methods
The melting range of the synthesized compounds was performed by LAB
INDIA visual  melting point  apparatus  and  is  uncorrected.  The IR  spectra  of  the
synthesized  compounds  were  recorded  on  Shimdzu  FT-IR  spectrometer  with
potassium  bromide  pellets.  Mass  spectra  of  the  synthesized  compounds  were
performed by using the instrument Shimdzu GCMS QP 5000. The  1H-NMR and
spectra  of  the  synthesized  compounds  were  performed  by  using  the  instrument
AVANCE 300 MHZ the solvent system used for the study was DMSO.
4.2 Scheme of Work
            In the present investigation, involving reactions of isatin with a view to
synthesize  some  biologically  active  compounds,  it  has  been  felt  worth  while  to
study  the  condensation  reaction  of  3-[(2)-(phenyl  methylidene)  hydrazono]-1,3-
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dihydro-2H-benzo[g]indol-2-one with different aryl aldehydes, as such  reactions are
not reported so far, and also to evaluate the products, biologically. The synthesis of
title compounds could be achieved by the Scheme 17.
I. α-Naphthyl amine.
II. (2)-Hydroxyimino-N-(naphthalene-1-yl) ethanamide.
III. 1H-benzo[g]indole-2, 3-dione.
IV. 3-Hydrazinylidene-1, 3-dihydro-2H-benzo[g]indole-2-one.
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V. 3-[(2)-(phenyl  methylidene)  hydrazono]-1,  3-dihydro-2H-benzo[g]indol
-2-ones.
R =  H,  4-OCH3 ,  4-OH-3- OCH3,  4-Cl ,  4-NO2,  4-F,  3,4-( OCH3)2,  2-OH,
4-N(CH3 )2 ,  1-CH=CH-
Scheme 17: Synthesis of 3-[(2)-(phenyl methylidene) hydrazono]-1, 3-dihydro-2H-
benzo[g]indol-2-one derivatives.
4.3 General Procedure
STEP I - Synthesis of (2)-(hydroxyimino)-N-(naphthalene-1-yl) ethanamide (II)
                 In a 5 lit. R.B. flask were placed chloral hydrate 90g. (0.54 mole) and
1200 ml of water.  To this solution, were then added crystallized sodiumsulphate
(1300 g) followed by a solution of an alpha-Naphthyl amine (0.5 mol) (I) in 300 ml
of water and concentrated hydrochloric acid (0.52 mol). Finally, a solution of 110g.
Of hydroxylamine hydrochloride (1.58 mol) in 500 ml of water was added.  The
contents of flask were heated over a wire-gauge by a meker burner.  So that vigorous
boiling  begins  in  about  45  minutes.   After  1-2  minutes  of  vigorous  boiling the
reaction  was  complete.   During  the  heating  period  itself  the  crystals  of
isonitrosoacetanilide started separating out.  On cooling under the current of water
the entire product was solidified.  It was filtered under suction, air dried and purified
by recrystallization from suitable solvent (s).
STEP II - Synthesis of 1H-benzo[g]indol-2, 3-dione (III) 
                   Sulfuric acid ( d. 1.84, 326 ml) was warmed to 50ºC in a one-liter R.B.
flask fitted with an efficient mechanical stirrer and  to this, finely powdered and 2-
(hydroxyimino)-N-(naphthalen-1-yl)ethanamide (0.46 mol) (II) was added at such a
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rate  so  as  to  maintain  the  temperature  between  60  and  70º C,  but  not  higher.
External cooling was applied at this stage so that the reaction could be carried but
more  rapidly.   After  the  addition  of  isonitroso  compound  was  completed  the
temperature of the solution was raised to 80C and maintained at that temperature for
10 minutes, to complete the reaction. Then, the reaction mixture was cooled to room
temperature and poured on crushed ice (2.5 kg).  After standing for about half-an-
hour, the product separated was filtered, washed several times with small portions of
cold  water  and  dried.  Purification  of  the  compound  was  effected  by
recrystallisation from methanol.
STEP III - Synthesis of 3-hydrazinylidene-1, 3-dihydro-2H-benzo[g]indol-2-
one (IV)
                   Equimolar quantity (0.004 mol) of 1H-benzo[g]indole-2, 3-dione (III)
and hydrazine were dissolved in 10 ml of warm methanol and refluxed for 30 min.
After  standing  for  approximately  24  h  at  room  temperature,  the  product  was
separated by filtration. The compound was vaccum dried and recrystallized from
warm methanol.
STEP IV - Synthesis of 3-[(2)-(phenyl methylidene) hydrazono]-1, 3-dihydro-
2H-benzo[g]indol-2-ones (V) 
                     Equimolar quantity (0.01 mol) of 3-hydrazinylidene-1, 3-dihydro-2H-
benzo[g]indol-2-one  (IV),  an  appropriate  aromatic  aldehyde  (0.01  mol)  and  few
drops of glacial acetic acid (0.01 mol) were dissolved in 10 ml of warm methanol
and refluxed for 4 h.  After standing for approximately 24 h at room temperature, the
products were separated by filtration. The products obtained were vacuum dried and
recrystallized from warm methanol. The synthesized compounds were characterized
by the physical and spectral data.
4.4 Chromatographic studies of synthesized compounds
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Thin Layer Chromatography
                    Thin Layer Chromatography or TLC is a solid-liquid form of
chromatography here the stationary phase is a polar absorbent and the mobile phase
can be a single solvent or combination of solvents. TLC is inexpensive technique
and quick that can be used for determine the number of components in a mixture,
verify a substances identity, monitor the process of a reaction, determine appropriate
condition for column chromatography, analyze the fractions obtained from column
chromatography.   
Materials and Methods
1. Preparation of plates
           Silica gel G was mixed in a glass mortar to smooth consistency with the
requisite amount of water and slurry was quickly transferred to the spreader. The
mixtures have been spread over the plates in thickness of 0.2 mm and allow setting
into a suitable holder and after 30 minutes, plates were dried at 120ºC, for further
activation of the absorbent.
2. Sample application
            About 2 mm of absorbent from the edge of plate was removed to give
sharply defined edges. 2-5 µl volumes of synthesized compounds were spotted with
the help of capillary tubes, just above 2 cm of the bottom of coated plates.
3. Development chamber
          The chromatographic chamber was lined with filter paper dipping into mobile
phase  so  as  to  maintain  the  atmospheric  saturation  with  solvent  vapors  in  the
chamber. The solvent front was allowed to rise to distance of about 12 cm from the
base line on the plate was removed from the tank and allowed to dry in the air.
Dept. of Pharmaceutical Chemistry           J.K.K. Nattraja College of Pharmacy
4
7
Chapter 4 Experimental Work
4. Solvent system
         The choice of best developing solvent is one of the most important decisions in
practical TLC by review of literature survey on by knowing nature of compounds,
this solvent system used is chloroform: ethyl acetate (9:1).
5. Detection of components
           The spots were visualized under Iodine chamber.    
4.5 Physico – chemical and spectral data of synthesized compounds
             Using above procedure, 10 compounds (Va-Vj) were synthesized and their 
physic-chemical and spectral data has given below,
Spectral data of (2)-(hydroxyimino)-N-(naphthalen-1-yl)ethanamide (II).  
Molecular formula : C12H10N2O2
Molecular weight : 214
 Melting point : 175-176ºC
Solubility                     : Methanol, Ethanol.
TLC Rf (solvent)       : 0.4 (Chloroform: Ethyl acetate; 9:1)
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IR (KBr) Cm-1 : Naphthalene(1571.91),
                    C-N(876.79),
N-H(3166.10),
C=O(1682.58), 
C=N(1571.91),
O-H(1036.86).
Mass spectra : Molecular ion (M. +) at m/z = 214
Spectral data of 1H-benzo[g]indol-2, 3-dione (III).
Molecular formula : C12H7NO2
Molecular weight : 197
Melting point : 183ºC
Solubility                   : Methanol, Ethanol.
TLC Rf (solvent) : 0.5 (Chloroform: Ethyl acetate; 9:1)
IR (KBr) Cm-1 : Naphthalene(1587.11),
C-N(1387.48),
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                                          N-H(3195.58),
                                          C=O(1717.33).                                      
1H NMR : 6.6-6.9 (m , 6H, Ar-H)
7.2 ( s,1H, NH)
Mass spectra : Molecular ion (M. +) at m/z = 197
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Spectral data of 3-hydrazinylidene-1, 3-dihydro-2H-benzo[g]indol-2-one (IV)
Molecular formula : C12H9N3O
Molecular weight : 211
Melting point : 192-194ºC
Solubility                   : Methanol, Ethanol.
TLC Rf (solvent) : 0.45 (Chloroform: Ethyl acetate; 9:1)
IR (KBr) Cm-1 : Naphthalene (1587.11),
C-N (1387.43),
N-H (3195.58),
C=O (1720.08),
C=N (1623.98),
                  N-H (2918.07).
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SAMPLE - Va
Equimolar  quantity  (0.01mol)  of  3-hydrazinylidene-1,  3-dihydro-2H-
benzo[g]indol-2-one (IV), an appropriate quantity of benzaldehyde (0.01 mol) and
few  drops  of  glacial  acetic  acid  (0.01  mol)  were  dissolved  in  10  ml  of  warm
methanol  and refluxed for  4  h.   After  standing for  approximately 24 h at  room
temperature, the product is separated by filtration. The product obtained is vaccum
dried and recrystallized from warm methanol. The synthesized compound (orange
colored) is characterized by the physical and spectral data.
HN
O
N N CH H
Molecular formula : C19H13ON3 
Molecular weight : 299.32
Melting point : 140-142C
Yield : 67%w/w
Solubility : Methanol, Ethanol.
 TLC Rf (solvent) : 0.82 (Chloroform: Ethyl acetate; 9:1)                                                     
IR(KBr) cm-1 : Naphthalene (1550.03), N-H (3190.58), C=O (1748.03),
C=N (1620.76), Phenyl (845.78), C-H(2924.25).
1H NMR(ο ppm) : 10.420  (1H, s), 3.763 (2H, bs, 2δNH2),
                                             1.246   (4H, pyrrolic protons), 2.993 (4H, protons),
7.068 (1H, s, C- 5H),
6.004 -8.47 (10 H, aromatic protons).
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SAMPLE – Vb
Equimolar  quantity  (0.01  mol)  of  3-hydrazinylidene-1,3-dihydro-2H-
benzo[g]indol-2-one (IV), an appropriate quantity of 4-methoxy benzaldehyde (0.01
mol) and few drops of glacial acetic acid (0.01 mol) were dissolved in 10 ml of
warm methanol and refluxed for 4 h.  After standing for approximately 24 h at room
temperature, the product is separated by filtration. The product obtained is vaccum
dried and recrystallized from warm methanol. The synthesized compound (reddish
brown colored) is characterized by the physical and spectral data.
HN
O
N N CH OCH3
Molecular formula : C20H15O2N3 
Molecular weight : 329.35
Melting point : 146οC
Yield : 54%w/w
Solubility : Methanol, Ethanol.
TLC Rf (solvent) : 0.68 (Chloroform: Ethyl acetate; 9:1)
IR(KBr) cm-1 : Naphthalene (1565.08), N-H (3198.05), C=O (1750.09),
C=N (1641.11), Phenyl (836.10), C-O-C (1260.29),
                     Methyl C-H(2857.04).
1H NMR(ο ppm) : 1.248 & 2.511 (4H pyrolic protons), 3.305 (2H, s, NH), 
7.036 (1H, s, C-5H), 10.420 (methoxy).
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SAMPLE – Vc
Equimolar  quantity  (0.01  mol)  of  3-hydrazinylidene-1,3-dihydro-2H-
benzo[g]indol-2-one  (IV),  an  appropriate  quantity  of  4-hydroxy-3-methoxy
benzaldehyde  (0.01  mol)  and  few drops  of  glacial  acetic  acid  (0.01  mol)  were
dissolved in 10 ml of warm methanol and refluxed for 4 h.  After standing for 24 h at
room temperature,  the product is  separated by filtration.  The product obtained is
vaccum dried and recrystallized from warm methanol. The synthesized compound
(pale brown colored) is characterized by the physical and spectral data.
HN
O
N N CH OH
OCH3
Molecular formula : C20H15O3 N3 
Molecular weight : 345.35
Melting point : 130-131δC
Yield : 91%w/w
Solubility             : Methanol, Ethanol.
 TLC Rf (solvent) : 0.57 (Chloroform: Ethyl acetate; 9:1)
IR(KBr) cm-1 : Naphthalene (1559.18), N-H (3039.33), C=O (1739.08),
C=N (1640.24), Phenyl (810.30), C-O-C (1283.47),
Methyl C-H(2923.99), O-H(3435.06).
1H NMR(ο ppm) : 7.114 (1H, s, C-5H), 10.420 (1H,phenolic), 
1.248 (H, pyrolic protons), 3.301 (H, 2δ NH).
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SAMPLE – Vd
                 Equimolar quantity (0.01 mol) of 3-hydrazinylidene-1,3-dihydro-2H-
benzo[g]indol-2-one  (IV),  an  appropriate  quantity of  4-chloro  benzaldehyde(0.01
mol) and few drops of glacial acetic acid (0.01 mol) were dissolved in 10 ml of
warm methanol and refluxed for 4 h.  After standing for approximately 24 h at room
temperature, the product is separated by filtration. The product obtained is vaccum
dried and recrystallized from warm methanol. The synthesized compound (bluish
red colored) is characterized by the physical and spectral data.
HN
O
N N CH Cl
Molecular formula : C19H12OCl N3 
Molecular weight : 333.77
Melting point : 132-134οC
Yield : 48%w/w
Solubility                         : Methanol, Ethanol.
TLC Rf (solvent) : 0.64 (Chloroform: Methanol; 9:1)
IR(KBr) cm-1 : Naphthalene (1581.10), N-H (3096.28), C=O (1760.52),
C=N (1634.34), Phenyl (880.81), C-Cl(760.26).
1H NMR(ο ppm) : 7.150 (1H, s, C-5H), 1.247 (H, pyrolic protons),
3.327(H, 2δ NH).
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SAMPLE – Ve
Equimolar  quantity  (0.01  mol)  of  3-hydrazinylidene-1,3-dihydro-2h-
benzo[g]indol-2-one (iv), an appropriate quantity of 4-nitro benzaldehyde (0.01 mol)
and few drops of glacial acetic acid (0.01 mol) were dissolved in 10 ml of warm
methanol  and refluxed for  4  h.   After  standing for  approximately 24 h at  room
temperature, the product is separated by filtration. The product obtained is vaccum
dried and recrystallized from warm methanol. The synthesized compound (yellowish
red colored) is characterized by the physical and spectral data.
HN
O
N N CH NO2
Molecular formula : C19H12O N4 
Molecular weight : 344.32
Melting point : 152-154οC
Yield : 76%w/w
Solubility : Methanol, Ethanol.
 TLC Rf (solvent) : 0.48 (Chloroform: Ethyl acetate; 9:1)
IR(KBr) cm-1 : Naphthalene (1599.32), N-H (3956.36), C=O (1740.27),
C=N (1645.66), Phenyl (824.81), Ar-NO2 (1384.61, 
1444.16), C-N(719.98).
1H NMR(ο ppm) : 1.241 & 2.514 (H, pyrrolic protons), 3.315 (1H, 2δ NH), 
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7.313 (1H, s, C-5H), 6.814-8.403 (9H, aromatic 
protons).
SAMPLE - Vf 
             Equimolar quantity (0.01 mol) of 3-hydrazinylidene-1,3-dihydro-2H-
benzo[g]indol-2-one  (IV),  an  appropriate  quantity  of  4-floro  benzaldehyde  (0.01
mol) and few drops of glacial acetic acid (0.01 mol) were dissolved in 10 ml of
warm methanol and refluxed for 4 h.  After standing for approximately 24 h at room
temperature, the product is separated by filtration. The product obtained is vaccum
dried and recrystallized from warm methanol. The synthesized compound (crimson
red colored) is characterized by the physical and spectral data.
HN
O
N N CH F
Molecular formula : C19H12OF N3
Molecular weight : 317.31
Melting point : 171οC
Yield : 92%w/w
Solubility : Methanol, Ethanol.
TLC Rf (solvent) : 0.73 (Chloroform: Ethyl acetate; 9:1)
IR(KBr) cm-1 : Naphthalene (1549.98), N-H (3192.62), C=O (1752.21),
C=N (1636.63), Phenyl (840.28), C-F(1233.74).
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1H NMR(ο ppm) : 1.189 & 2.902 (H, benzylic protons), 3.563 (1H, 2δ NH),
7.088 (1H, s, C-5H).
SAMPLE – Vg 
                 Equimolar quantity (0.01 mol) of 3-hydrazinylidene-1,3-dihydro-2H-
benzo[g]indol-2-one(IV),an  appropriate  quantity  of  3,4-dimethoxy
benzaldehyde(0.01  mol)  and  few  drops  of  glacial  acetic  acid  (0.01  mol)  were
dissolved in 10 ml of warm methanol and refluxed for 4 h.  After standing for 24 h at
room temperature,  the product is  separated by filtration.  The product obtained is
vaccum dried and recrystallized from warm methanol. The synthesized compound
(reddish brown colored) is characterized by the physical and spectral data.
HN
O
N N CH OCH3
OCH3
Molecular formula : C21H17O 3N3
Molecular weight : 359.37
Melting point : 124-126οC
Yield : 46%w/w
Solubility : Methanol, Ethanol.
TLC Rf (solvent) : 0.76 (Chloroform: Ethyl acetate; 9:1)
IR(KBr) cm-1 : Naphthalene (1562.10), N-H (3184.10), 
C=O (1738.26), C=N (1622.10), Phenyl (815.80),
C-O-C (1259.76, 1249.16), C-H(2923.38)..
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1H NMR(ο ppm) : 8.317 (3H, s, methoxy protons), 1.244 & 2.510 (H, 
pyrrolic and benzylic), 3.304 (1H, 2δNH), 6.648 (1H, s, 
C-5H), 6.648-8.317 (8H, aromatic protons).
SAMPLE – Vh
          Equimolar quantity (0.01 mol) of 3-hydrazinylidene-1,3-dihydro-2H-
benzo[g]indol-2-one (IV), an appropriate quantity of 2-hydroxy benzaldehyde(0.01
mol) and few drops of glacial acetic acid (0.01 mol) were dissolved in 10 ml of
warm methanol and refluxed for 4 h.  After standing for approximately 24 h at room
temperature, the product is separated by filtration. The product obtained is vaccum
dried and recrystallized from warm methanol. The synthesized compound (orange
colored) is characterized by the physical and spectral data.
HN
O
N N CH
OH
Molecular formula : C19H13O2N3
Molecular weight : 315.32
Melting point : 146οC
Yield : 72%w/w
Solubility : Methanol, Ethanol.
TLC Rf (solvent) : 0.84 (Chloroform: Ethyl acetate; 9:1)
IR(KBr) cm-1 : Naphthalene (1559.18), N-H (3039.33), 
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C=O (1739.08), C=N (1640.24),
Phenyl (810.30), C-OH(3435.06).
SAMPLE – Vi  
              Equimolar quantity (0.01 mol) of 3-hydrazinylidene-1,3-dihydro-2H-
benzo[g]indol-2-one  (IV),  an  appropriate  quantity  of  4-(N,N-dimethyl)amino
benzaldehyde(0.01  mol)  and  few  drops  of  glacial  acetic  acid  (0.01  mol)  were
dissolved in 10 ml of warm methanol and refluxed for 4 h.  After standing for 24 h at
room temperature,  the product is  separated by filtration.  The product obtained is
vaccum dried and recrystallized from warm methanol. The synthesized compound
(dark red colored) is characterized by the physical and spectral data.
HN
O
N N CH N
CH3
CH3
Molecular formula : C21H18N4O
Molecular weight : 342
Melting point : 1580C
Yield : 94%w/w
Solubility : Methanol, Ethanol.
TLC Rf (solvent) : 0.61 (Chloroform: Ethyl acetate; 9:1)
IR (KBr) Cm-1 : Naphthalene (1582.18), N-H (3080.63),
C=O (1726.11), C=N (1621.58), Phenyl (810.09), 
t-amino (2921.85), C-N(945.57), Methyl C-H (2872.42).
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1H NMR(ο ppm) : 2.913 & 2.513 (3H, s, methyl  protons),
                                       6.766 & 6.746 (1H, s, C-5H),
                                       7.212-7.357 (8H, aromatic protons).
Mass spectra : Molecular ion (M. +) at m/z = 343
SAMPLE – Vj
 Equimolar  quantity  (0.01mol)  of  3-hydrazinylidene-1,  3-dihydro-2H-
benzo[g]indol-2-one  (IV),  an  appropriate  quantity  of  cinnamaldehyde (0.01  mol)
and few drops of glacial acetic acid (0.01 mol) were dissolved in 10 ml of warm
methanol  and refluxed for  4  h.   After  standing for  approximately 24 h at  room
temperature, the product is separated by filtration. The product obtained is vaccum
dried  and  recrystallized  from warm methanol.  The  synthesized  compound  (light
orange colored) is characterized by the physical and spectral data.
HN
O
N N C
H
C
H
C
H
Molecular formula : C21H15ON3
Molecular weight : 325.13
Melting point : 148-150δC
Yield : 64%w/w
Solubility                   : Methanol, Ethanol.
 TLC Rf (solvent)       :   0.68 (Chloroform: Ethyl acetate; 9:1)
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IR(KBr) cm-1 : Naphthalene (1557.28), N-H (3431.44), C=O (1739.46),
C=N (1635.10),  Phenyl (888.33), Allyl (1650.28).
1H NMR(ο ppm) : 10.431 (1H, s), 1.241 & 2.518 (2H,pyrrolic and benzylic),
3.314 (1H, 2δNH), 7.798 (1H, s, C-5H).
7.117-9.177 (9 H, aromatic protons).
Table 3: Physical data of 3-[(2-phenyl methylidene) hydrazono]-1, 3-dihydro-
2H-benzo[g]indol-2-ones (v)
S.N
o
Compd
s
Substituent
s
R
Mol.
Formula
Mol.
Weigh
t
M.P.
(ºC)
Yield
(%)w/
w
Rf
valu
e
1. Va H C19H13 N3O 299.32 140-142 67 0.82
2. Vb 4-OCH3 C20H15 N3O2 329.35 146 54 0.68
3. Vc 4-OH, 3-OCH3 C20H15 N3O3 345.35 130-131 91 0.57
4. Vd 4-Cl C19H12ClN3O 333.77 132-134 48 0.64
5. Ve 4-NO2 C19H12 N4O 344.32 152-154 76 0.48
6. Vf 4-F C19H12 FN3O 317.31 171 92 0.73
7. Vg 3-OCH3,4-OCH3 C21H17 N3O3 359.37 124-126 46 0.76
8. Vh 2-OH C19H13 N3O2 315.32 145-146 72 0.84
9. Vi 4-N(CH3)2 C21H18N4O 342.19 158 94 0.61
10. Vj 1-CH═CH- C21H15N3O 325.13 148-150 64 0.68
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5. BIOLOGICAL SCREENING
5.1 Introduction
Microorganism
             A microorganism or microbe is an organism that is microscope (too small to
be  seen  by  the  naked  human  eye).A  subject  that  began  with  Anton  van
Leeuwenhoek’s discovery of microorganism in 1675, using a microscope of his own
design.
                Microorganisms are incredibly diverse and include bacteria, fungi,
archaea, and protests, as well as some microscopic plants and animals. Microbes are
also exploited by people in biotechnology,  both in  traditional  food and beverage
preparation, as well as modern technologies based on genetic engineering. However,
pathogenic  microbes  are  harmful,  since  they  invade  and  grow  within  other
organisms, causing diseases that kill millions of people, other animals, and plants
every year.
Bacteria
             Bacteria are unicellular microorganisms. Typically a few micrometers in
length, bacteria have a wide range of shapes, ranging from spheres to rods to spirals.
Bacteria are ubiquitous in every habitat on Earth, growing in soil, acidic hot springs,
radioactive waste, seawater, and deep in the Earth’s crust. 
            Although the vast majority of these bacteria are rendered harmless or
beneficial  by the protective effects of the immune system, a  few are pathogenic
bacteria and cause infectious diseases. In developed countries, antibiotics are used to
treat  bacterial  infections  and  in  various  agricultural  processes,  so  antibiotic
resistance is becoming common. 
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Pathogenic bacteria
            If bacteria form a parasitic association with other organisms, they are classed
as pathogens. Pathogenic bacteria are a major cause of human death disease and
cause infections such as tetanus, typhoid fever, diphtheria, syphilis, cholera,  food
borne illness,  leprosy and tuberculosis.  A pathogenic cause for a  known medical
disease may only be discovered many years after, as was the case with Helicobacter
pylori and peptic ulcer disease.
             Each species of pathogen has a characteristic spectrum of interactions with
its  human hosts.  Some organisms  such  as  staphylococcus  and  streptococcus  can
cause skin infections, pneumonia, and meningitis, a systemic inflammatory response
producing shock, massive vasodilatation and death. Yet these organisms are also part
of  the normal  human flora and usually exist  on the skin or  in  the nose without
causing any disease at all. Other organisms invariably cause disease in humans, such
as Rickettsia, which are obligate intracellular parasites able to grow and reproduce
only within the cells of other organisms. One species of Rickettsia causes typhus,
while another causes Rocky Mountain spotted fever. Chlamydia, another phylum of
obligate  intracellular  parasites,  contains  species  that  can  cause  pneumonia,  or
urinary tract infection and may be involved in coronary heart disease. 
Treatment
             Bacterial infections may be treated with antibiotics, which are classified as
bactericidal  if  they  kill  bacteria,  or  bacteriostatic  if  they  just  prevent  bacterial
growth. There are many types of antibiotics and each class inhibits a process that is
different in the pathogen from that found in the host. Examples of how antibiotics
produce selective toxicity are chloramphenicol  and puromycin,  which inhibit  the
bacterial ribosome, but not the structurally different eukaryotic ribosome. Antibiotics
are used both in treating human disease and in intensive farming to promote animal
growth,  where  they  may be  contributing  to  the  rapid  development  of  antibiotic
resistance  in  bacterial  populations.  Disinfectants  such  as  bleach  are  used  to  kill
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bacteria or other pathogens on surfaces to prevent contamination and further reduce
the risk of infection.   
Antibiotic
                An antibiotic is a chemotherapeutic agent that inhibits or abolishes the
growth of micro-organisms, such as bacteria, fungi, or protozoa. The term originally
referred to any agent with biological  activity against  living organisms. However,
“antibiotic” now is used to refer to substances with anti-bacterial, anti-fungal,  or
anti-parasitical  activity.  With advances in organic chemistry many antibiotics  are
relatively small molecules with a molecular weight less than 2000 Da.
               Most antibacterial antibiotics do not have activity against viruses, fungi, or
other microbes. Anti-bacterial antibiotics can be categorized based on their target
specificity. “narrow-spectrum” antibiotics target particular types of bacteria, such as
Gram-negative or Gram-positive bacteria, while broad spectrum antibiotics affect a
wide range of bacteria.
               The effectiveness of individual antibiotics varies with the location of the
infection, the ability of the antibiotic to reach the site of infection, and the ability of
the microbe to inactivate or excrete the antibiotic. Some anti-bacterial  antibiotics
destroy bacteria  (bactericidal),  whereas  others  prevent  bacteria  from multiplying
(bacteriostatic).
             In the last few years, three new classes of antibiotics have been brought in to
clinical use. This fallows a 40-year hiatus in discovering new classes of antibiotic
compounds.
Classification of antibiotics
Eg: Amikacin, Streptomycin, neomycin, gentamycin.
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Cephalosporins
First generation Eg: cefadroxil, cefazolin.
Second generation Eg: cefuroxime, cefmandole.
Third generation Eg: cefixime, cefotoxime.
Fourth generation Eg: cefepime.
Glycopeptides
Eg: vancomycin
Macrolides
Eg: erythromycin, clarythromycin
Penicillins
Eg: ampicillin, amoxicillin.
Sulphonamides
Eg: sulphamethazole, sulfasalazine.
Quinolones
Eg: ciprofloxacin, norfloxacin.
Tetracyclines
Eg: tetracycline, doxycycline.
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Others
Eg: clindamycin, vancomycin.
Fungus
The fungi are heterotrophic organisms characterized by a chitinous cell wall,
and in the majority of species, filamentous growth as multi cellular hyphae forming
a  mycelium;  some  fungal  species  also  grow  as  single  cells.  The  fungi  are  a
monophyletic  group  that  is  phylogenetically  clearly  distinct  from  the
morphologically similar slim molds (myxomycetes) and water molds (oomycetes).
Many fungal species have long been used as a direct source of food, such as
mushrooms and truffles and in fermentation of various food products, such as wine,
beer, and soy sauce. More recently, fungi are being used as sources for antibiotics
and various enzymes, such as cellulases, pectinases,  and proteases,  important for
industrial use or as active ingredients of detergents. Several species of the fungi are
significant pathogens of humans and other animals, and losses due to diseases of
crops or food spoilage caused by fungi can have a large impact on human food
supply and local economies.
As pathogens and parasites
                   However many fungi are parasites on plants, animals, and other fungi.
Serious fungal pathogens of many cultivated plants causing extensive damage and
losses to agriculture and forestry include the rice blast fungus Magnaporthe oryzae,
tree pathogens such as Ophiostoma ulmi and Ophiostoma novo-ulmi causing Dutch
elm disease, and Cryphonectria parasitica responsible for chestnut blight, and plant-
pathogenic fungi in the genera Fuserium, Ustilago,  Alternaria, and Cochliobolous;
fungi with the potential to cause serious human diseases, especially in persons with
immune-deficiencies,  are  in  the  genera  Aspergillus,  Candida,  Cryptococcus,
Histoplasma, and Pneumocystis. Several pathogenic fungi are also responsible for
relatively minor human diseases, such as athlete’s foot and ringworm. Some fungi
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are predators of nematodes, which they capture using an array of devices such as
constricting rings or adhesive nets.
Treatment 
            An antifungal drug is medication is used to treat fungal infections such as
athlete’s foot,  ringworm, candidiasis (thrush),  serious systemic infections such as
cryptococcal meningitis, and others.
Classification of antifungals
Polyenes
Eg: Nystatin, Amphotericine B, and Candicin.
Imidazoles 
Eg: Miconazole, Ketoconazole, Clotrimazole.
Triazoles 
Eg: Fluconazole, Itraconazole, Isavuconazole.
Allylamines 
Eg: Terbinafine, Amorolfine, Naftifine.
Echinocandins 
Eg: Anidulafungin, Capsofungin, Micafungin.
Others 
Eg: Ciclopirox, Flucytosine, Griseofulvin.
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Antimicrobial 
               An  antimicrobial is a substance that kills or inhibits the growth of
microbes such as bacteria, fungi, or viruses. Antimicrobial drugs either kill microbes
(microbicidal) or prevent the growth of microbes (microbistatic).
             However, the future effectiveness of antimicrobial therapy is somewhat in
doubt.  Microorganisms,  especially  bacteria,  are  becoming  resistant  to  more  and
more  antimicrobial  agents.  Bacteria  found  in  hospitals  appear  to  be  especially
resilient, and are causing increasing difficulty for the sickest patients-those in the
hospital. Currently bacterial resistance is combated by the discovery of new drugs.
However, microorganisms are becoming resistant more quickly than new drugs are
being found, thus future research in antimicrobial therapy may focus on finding how
to overcome resistance to antimicrobials, or how to treat infections with alternative
means (antibacterial activity), fungi (antifungal activity), viruses (antiviral activity),
or parasites (antiparasitic activity).
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History of antibacterial drug introductions and approval
Introduced year Class of drug
1935 Sulfonamides
1941  β-lactams(Penicillin)
1944 Chloramphenicol
1950 Tetracyclines
1952 Macrolides/ Lincosamides/ streptogramins
1956 Glycopeptides
1957 Rifamycins
1959 Nitromidazoles
1962 Quinolones Kefauver-Harris Amendments 1962
1968 Trimethoprim
2000 Oxazolidinones
2003 Lipopeptides
Dept. of Pharmaceutical Chemistry           J.K.K. Nattraja College of Pharmacy
9
2
Chapter 5 Biological Screening
Fig. No. 28 Mechanism of action of antimicrobial agents88
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All antimicrobial agents act in five different modes: 
1. The inhibition of cell wall synthesis: 
The  cell  wall  of  the  bacterium  consists  of  macromolecular  network  called
Peptidoglycon.  Peptidoglycon  is  found only in  bacterial  cell  wall.  Penicillin  and
certain other antibiotics prevent the synthesis of intact peptidoglycon consequently
the cell wall wills greatly weakend in its integrity and the cell wall undergoes lysis
leading to cell death.
2. Inhibition of protein synthesis: 
Protein  synthesis  is  a  common  feature  of  both  prokaryotic  and  eukaryotic
organism.   A significant  difference  in  the  machinery  of  protein  synthesis,  the
structure  of  ribosomes.  The  difference  in  ribosomal  structure  accounts  for  the
selectivity toxicity of antibiotics that affect  protein synthesis. The antibiotics like
Chloramphenicol, Erythromycin, Streptomycin and Tetracyclines act on the protein
synthesis process. 
3. Injury to plasma membrane: 
Certain  antibiotics  like  polypeptide  antibiotics  bring  about  changes  in  the
permeability of the plasma membrane. These changes result in the loss of important
metabolites from the microbial cell. Polymixin B causes disruption of the plasma
membrane by attaching to the phospholipids of the membrane.
4. The inhibition of nucleic acid synthesis:
A number  of  antibiotics  interfere  with  the  process  of  DNA replication  and
transcription  in  microorganisms.  Some  drugs  with  this  mode  of  action  have
extremely limited usefulness because they interfere with mammalian DNA and RNA
as well. Rifampicin and Quinolones are widely used in chemotherapy because they
are more selectively toxic.
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5. Inhibition of synthesis of essential metabolites: 
A  particular  enzymatic  activity  of  a  microorganism  can  be  competitively
inhibited by a substance (anti metabolite) that closely resembles the normal substrate
for the enzyme. An example of competitive inhibition is the relationship between the
anti metabolite sulfonamide and p-amino benzoic acid (PABA).
In  view of  varied biological  and pharmacological  importance of  different
Isatins,  it  has  been  prompted  us  to  evaluate  the  new series  of  3-[(2)  -  (phenyl
methylidene)  hydrazono]-1,  3-dihydro-2H-benzo[g]indol-2-ones  (Va-j)  for
antimicrobial and antifungal activity.
MATERIALS AND METHODS
Four  bacterial  test  organisms  such  as  Bacillus  subtilis (MTCC  441),
Staphylococcus aureus (MTCC 96),  Escherichia coli (MTCC 722),  and Proteus
vulgaris (MTCC 109) were selected and obtained from the Institute Of Microbial
Technology,  Chandigarh.  Cultures  of  test  organisms were maintained on nutrient
agar slants and were sub cultured in Petri dishes prior to testing. The media used was
nutrient agar, nutrient broth procured from Himedia Laboratories, Mumbai. Stock
solutions  of  the  synthesized  compounds  were  prepared  in  the  different
concentrations,  viz.,50  µg/ml,  100  µg/ml,  150  µg/ml,  200  µg/ml  using
dimethylsulfoxide (DMSO) as solvent for antibacterial activity.
5.2 ANTIBACTERIAL ACTIVITY
The  antibacterial  activity  of  title  compounds  was  assayed  against  four
different strains of bacteria by agar diffusion method.
Two Gram-Positive Bacteria: Bacillus subtilis and Staphylococcus aureus
Two Gram-Negative Bacteria: Escherichia coli and Proteus vulgaris 
Generally, the antibacterial activity of a compound is expressed in terms of
its ability to inhibit the growth of bacteria in nutrient broth or agar. The bacterial
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inhibition can be measured my two methods: one is serial dilution method and the
other  is  diffusion  method.  The  serial  dilution  method  is  very  useful  for  the
determination of  antimicrobial  activity.  It  is  not  much useful  for the quantitative
detection tests and also for the evaluation of large number of compounds. The agar
diffusion is of three types.
1. Cup-plate method (disc method)
2. Filter-paper strip method
3. Gradient plate method
The  method  adopted  in  this  investigation  was  cup-plate  method.  In  this
method, cups or discs of standard diameter are made in the nutrient agar medium,
containing standard bacterial inoculums. The test compounds were introduced into
the discs and the diameter of zone of inhibition was measured.
CULTURED MEDIUM
Nutrient broth was used for the preparation of inoculums of the bacteria and
the nutrient agar used for the screening method.
Composition of Medium, nutrient agar:
Peptone 5.0gm
Sodium chloride 5.0gm
Beef extract 1.5gm
Yeast extract  1.5gm
Agar 1.5gm
Distilled water 1000ml
PH 7.4 ± 0.2
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The test organism was sub cultured using nutrient agar medium. The tubes
containing sterilized medium were inoculated with respective bacterial strain. After
incubation at 37 ± 1ºC for 24 h, they were stored in refrigerator. The stock cultures
were maintained. Bacterial inoculum was prepared by transferring a loopful of stock
culture to nutrient broth. The flasks were incubated at 37 ± 1ºC for 48 h before the
experimentation.
Solution of  test  compounds were prepared by dissolving  10 mg each in
dimethylsulfoxide  (DMSO,10  ml).A  reference  standard  for  Gram-positive  and
Gram-negative bacteria was made by dissolving accurately weighed quantities of
Ampicillin in DMSO (10 µg/ml).
The  nutrient  agar  medium  was  sterilized  by  autoclaving  at  121ºC  (15
lb/sq.inch)  for  15  min.  Petri-plates,  tubes  and  flasks  plugged  in  cotton  were
sterilized in hot-air oven at 160ºC for an hour. Into each sterilized Petri-plate (10 cm
diameter),  about  27  ml  of  molten  nutrient  agar  medium  inoculated  with  the
respective strain  of  bacteria  (50 µl  of  inoculum into each plate)  was transferred
aseptically. The plates were left at room temperature to allow solidification. In each
plate, three discs of 6 mm diameter were made with a sterile borer. These solutions
at concentrations (200 µg/ml, 150 µg/ml, 100 µg/ml) was added to respective disc
aseptically and labeled accordingly. The plates were kept undisturbed for 1 hour at
room temperature to allow the diffusion of the solution properly in the nutrient agar
medium. After incubation of the plates at 37 ± 1ºC for 24 h, the diameter of zone
inhibition surrounding each of discs was measured with the help of an antibiotic
zone  reader.  All  the  experiments  were  carried  out  in  triplicate.  Simultaneously,
controls were maintained employing 0.1 ml of DMSO to observe the solvent effects
and the results were represented in Table-4. 
5.3 ANTIFUNGAL ACTIVITY
For the antifungal screening of synthesized compounds,  Candida albicans
and Yeast were used.
Sabourad dextrose agar medium (SDA)
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Mycological peptone - 10 gm
Dextrose - 14 gm
Agar - 17 gm
The  test  organisms  were  sub  cultured  using  SDA  medium.  The  tubes
containing sterilized medium were inoculated with test fungi and after incubation at
25ºC for 48 h, were stored at 4ºC in refrigerator. The inoculum was prepared by
taking a loopful of stock culture to about 5 ml of sabourad dextrose broth in a test
tube. The tubes were incubated at 25ºC for 48-72 h before use.
The  solution  of  test  compound  was  prepared  by  a  similar  procedure
described  under  the  antibacterial  activity.  A  reference  standard  solution  of
Clotrimazole (10 µg/ml) was prepared by dissolving 10 mg of Clotrimazole in 10 ml
of dimethylsulfoxide (DMSO).
The SDA medium was sterilized by autoclaving at 121ºC (15 lb/sq.inch) for
15 min. the Petri-plates were sterilized in hot-air oven at 160º C for an hour. Into
each sterilized Petri-plate about 27 ml of molten SDA medium was added. Incubated
at  30º C for 2 days. After 2 days of incubation, the medium free of contaminations
was spreaded with 50 µl of 48 h culturing. After solidification of the cups of 6 mm
diameter were made in each plate with sterile borer. Accurately 50 µl of 200 µg, 150
µg,  and  100 µg concentrations  of  test  solution was transferred to  the respective
Petri-plates aseptically and labeled accordingly.  The reference standard 50µl was
also added to the discs in each plate.
The plates were kept in refrigerator for one hour to allow the solution to
diffuse properly into the SDA medium. Then the plates were incubated at 26º C for
72 h at inverted position. The diameter of zone of inhibition was read with help of an
antibiotic zone reader. The experiment was performed in triplicate and the results
were represented in Table-5.
ANTIBACTERIAL ACTIVITY
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Table 4:  Antibacterial  activity  of  3-[(2-phenyl  methylidene)  hydrazono]-1,  3-
dihydro-2H-benzo[g]indole-2-one derivatives.
S.
No.
Substituents Conc. Zone of Inhibition (in mm)
Compds
 
       R Conc.
(µg/ml
)
B.subtilis S.aureu
s
E.coli P.vulgaris
1 Va H
100 8 9 8 9
150 10 12 11 10
200 13 13 11 12
2 Vb 4-OCH3
100 9 8 7 8
150 11 9 9 9
200 12 11 10 11
3 Vc 4-OH,3-OCH3
100 11 10 9 9
150 13 12 12 11
200 16 14 14 13
4 Vd 4-Cl 100 7 9 8 10
150 9 10 10 12
200 11 12 11 14
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5 Ve 4-NO2
100 8 12 9 12
150 16 13 11 14
200 12 14 12 15
6 Vf 4-F
100 10 13 12 10
150 13 16 13 13
200 15 18 14 14
7 Vg 3-OCH3,4-OCH3
100 9 8 9 9
150 12 11 11 12
200 14 13 12 13
8 Vh 2-OH
100 11 10 13 11
150 14 13 14 14
200 16 15 15 15
9 Vi 4-N(CH3)2
100 12 11 11 13
150 14 14 12 15
200 18 17 14 17
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10 Vj 1-CH=CH-
100 8 9 10 8
150 9 12 11 10
200 11 14 12 11
11 Standard Ampicilli
n
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ANTIFUNGAL ACTIVITY 
Table  5:  Antifungal  activity  of  3-[(2)-(phenyl  methylidene)  hydrazono]-1,  3-
dihydro-2H-benzo[g]indol-2-one derivatives.
S.
No.
Substituents     Conc. Zone of Inhibition 
(in mm)
Compounds R Conc. (µg/ml) C. albicans Yeast
1 Va H
100 9 9
150 11 10
200 14 12
2 Vb 4-OCH3
100 8 8
150 10 9
200 13 11
3 Vc 4-OH,   
  3-OCH3
100 9 10
150 13 11
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200 15 13
4 Vd 4-Cl
100 7 9
150 10 10
200 12 12
5 Ve 4-NO2
100 10 11
150 12 13
200 16 14
6 Vf 4-F
100 8 7
150 10 9
200 11 10
7 Vg 3-OCH3, 
  4-OCH3
100 9 8
150 11 10
200 13 11
8 Vh 2-OH
100 10 12
150 12 14
200 14 15
9 Vi 4-N(CH3)2
100 13 14
150 15 16
200 18 17
10 Vj 1-CH=CH-
100 10 9
150 12 10
200 14 12
11 Standard Clotrimazol
e
10 20 19
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6. RESULTS AND DISCUSSION
              Isatins (1H indole-2, 3- dione) are synthetically versatile substrates, where
they can be used for synthesis of a large variety of heterocyclic compounds, Such as
indoles & quinolines, and as raw material for drug synthesis. Isatin have also been
found  in  mammalian  tissue  and  their  function  as  a  modulator  of  biochemical
processes has been the subject of several discussions.
              The survey of the literature revealed that, isatin is a versatile lead molecule
for designing potential bioactive agents, and its derivatives were reported to possess
broad-spectrum  antimicrobial,  antiviral,  anticancer,  anti-inflammatory,  anxiety,
analgesic,  anticonvulsant,  antipsychotic  activities.  In  the  present  study,  we  have
investigated the 10 new isatin derivatives (Va-Vj), and tested for their antimicrobial
activity.     
               Isatin (1H-indole-  2,  3-dione)  was prepared by using Sandmeyer
methodology; the title compounds (Va-Vj) were prepared from isatin, by using the
reaction sequence in Scheme 17. 
               The newly Synthesized Isatin derivatives were purified by crystallization
and  chromatographic  techniques  (Thin  Layer  Chromatography).  The  chemical
structures  of  synthesized  compounds  were  confirmed  by  physico-chemical  and
spectral datas (IR, Mass and 1H NMR studies). 
             All the synthesized compounds were tested for in vitro antibacterial activity
by  the  agar  diffusion  method.  The  zone  of  inhibition  values  of  the  synthesized
compounds against  Bacillus subtilis,  Staphylococcus aureus, Escherichia coli  and
Proteus vulgaris were presented in Table 4. Ampicillin was used for the reference
for  inhibitory  activity  against  bacteria.  It  has  been  observed  that  all  the  tested
compounds were showed  mild to moderate activity  against the bacteria, compound
Vf (Fluro) was more potent  anti- bacterial agent against both gram (+Ve) and gram
(-Ve) organisms among all the test compounds. This was followed by compound Vi
(N-dimethyl), Ve (Nitro) and Vh (Hydroxy).            
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         The antifungal activities of the compounds were studied against  Candida
albicans  and Yeast. Clotrimazole was used for the reference for inhibitory activity
against fungi. All the tested compounds showed mild to moderate antifungal activity.
Compound Vi (N-dimethyl) was more potent anti fungal agent among all the test
compounds. This was followed by the compounds Vh (Hydroxy), Ve (Nitro) and Vc
(4-Hydroxy-3-methoxy).
It  has  been  felt  necessary  from  the  results  of  the  present  antimicrobial
investigations that there is a need for further advanced studies, at least on the few of
the test compounds which are found to be superior.
    Ravi raj A. Kusanur et al., 44 reported the synthesis of 4'-(coumarin-3-yl)
spiro  [3H-indol-3,  2'-1,  5-benzodiazepine]-2(1H)-one  and  evaluated  for  in  vitro
antibacterial activity. Among all the compounds, compound with R = 8-OCH3, R1 =
R2 = CH3 showed 88.83% of inhibition against B. subtilis and 77.77% of inhibition
against  E. coli as compared to the standard and other compounds were moderately
active.         
            Ankur patel et al. 87 reported the Synthesis and antimicrobial activity of some
new isatin derivatives, substitution of chloro, bromo or fluoro groups produced more
antimicrobial  activity.  Vijey  Anandhi  M  et  al., 88 reported  the  Synthesis  and
antimicrobial  activities  of  1-(5-substituted-2-oxoindolin-3-ylidine)-4-(substituted
pyridine-2-yl) thiosemicarbazide, showed the activity against Gram +Ve, Gram –Ve
bacteria and fungi. The order of antibacterial activity of the substituents at the 5th
position of isatin is Br > Cl > F. 
              From this investigation subtituents of fluoro, N-dimethyl, nitro and chloro
groups containing compounds showed good antimicrobial activity.
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7. CONCLUSION
Title compounds were showed mild to moderate activity against the bacteria.
 In conclusion, 
Vf  (Fluoro)  >  Vi  (N-dimethyl)  >  Ve  (Nitro)  >  Vh  (Hydroxy)  >  Vc  (4-
hydroxy-3-methoxy) > Vg (Dimethoxy) > Vj (Allyl) > Va (Hydro) > Vd (Chloro) >
Vb (Methoxy).
Fluoro,  N-Dimethyl,  Nitro  pharmacophore  containing  compounds  shows
significant lead optimization.
So further beneficial pharmacophore modifications in the design of isatin as
promising anti-bacterial agent.
The title compounds were showed mild to moderate activity against fungi.
 In conclusion, 
Vi (N-dimethyl) > Vh (Hydroxy) > Ve (Nitro) > Vc (4-hydroxy-3-methoxy)
> Vj (Allyl) > Va (Hydro) > Vg (Dimethoxy) > Vd (Chloro) > Vb (Methoxy) > Vf
(fluro).
N-Dimethyl,  Hydroxy,  and  Nitro  pharmacophore  containing  compound
shows significant lead optimization. 
So further beneficial pharmacophore modifications in the design of isatin as
promising anti-fungal agent.
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